Medplus Health Services Ltds subsidiary, Optival Health Solutions, received three drug license suspension orders resulting in estimated revenue losses of approximately Rs 0.35 Lacs, Rs 1.89 Lacs, and Rs 2.68 Lacs for different locations due to regulatory issues. Orders were received on September 2, 2024.